Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 17, 2024 - Issue
Submit an article Journal homepage
186
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Therapeutic Potential of Fingolimod in Diabetes Mellitus and Its Chronic Complications

Jie Li1 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050000, People’s Republic of China;2 Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, 063000, People’s Republic of China
,
Xinyu Nan1 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050000, People’s Republic of China
,
Yixuan Ma3 Graduate School, Hebei North University, Zhangjiakou, 075000, People’s Republic of China
,
Zhen Wang4 Department of Orthopedics, Handan First Hospital, Handan, 056000, People’s Republic of China
&
Hui Fang1 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050000, People’s Republic of China;2 Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, 063000, People’s Republic of ChinaCorrespondence[email protected]
Pages 507-516 | Received 23 Oct 2023, Accepted 19 Jan 2024, Published online: 01 Feb 2024

Figures & data

Figure 1 S1P metabolic pathway.

Figure 1 S1P metabolic pathway.

Figure 2 FTY720 acts on the above-mentioned organs to improve DM and its chronic complications through S1PR1, 3, 4, 5.

Figure 2 FTY720 acts on the above-mentioned organs to improve DM and its chronic complications through S1PR1, 3, 4, 5.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.